Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 6/20 | 0.59 |
| ▸ | RAMP3 | O60896 | 6/20 | 0.56 |
| ▸ | CALCR | P30988 | 6/20 | 0.56 |
| ▸ | NPY2R | P49146 | 7/20 | 0.55 |
| ▸ | NPY4R | P50391 | 7/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.55 |
| ▸ | NPY1R | P25929 | 5/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607357 | 0.89 | NPY2R (0.57) | CXCR4RAMP3CALCRNPY2RNPY4R | |
| SCHEMBL30658199 | 0.88 | NPY2R (0.63) | CXCR4RAMP3CALCRNPY2RNPY4R | |
| SCHEMBL30607285 | 0.87 | CXCR4 (0.58) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29531542 | 0.87 | NPY2R (0.63) | CXCR4CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30175378 | 0.86 | RAMP3 (0.56) | CXCR4RAMP3CALCRNPY2RNPY4R | |
| SCHEMBL31683295 | 0.86 | NPY2R (0.58) | CXCR4RAMP3CALCRNPY2RNPY4R | |
| SCHEMBL31474426 | 0.86 | RAMP3 (0.61) | CXCR4RAMP3CALCRNPY2RNPY4R | |
| SCHEMBL30428990 | 0.85 | RAMP3 (0.61) | CXCR4RAMP3CALCRNPY2RNPY4R | |
| SCHEMBL29903354 | 0.85 | RAMP3 (0.60) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30423163 | 0.85 | RAMP3 (0.60) | RAMP3CALCRNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350475-A1 | TRIGONELLINE MITIGATES CARDIOMYOPATHY CAUSED BY SARS-COV-2 SPIKE PROTEIN UNDER OBESITY | UNIVERSITY OF SOUTH CAROLINA (US) | 2024-10-24 | — | — | US | disclosed |